Aceragen Competitors and Similar CompaniesClear all
Aceragen's competitors and similar companies include Novartis Gene Therapies.
 Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. |  Novartis Gene Therapies Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases. | |
Founding Date | Founding Date 1989 | Founding Date 2010 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Durham, US HQ | Locations Bannockburn, US HQ |
Employees | Employees 3642% decrease | Employees 6603% decrease |
Financial | ||
Net income | Net income ($23.4m) (FY, 2022) | Net income ($218.1m) (FY, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 13.8m | Total funding raised $ 75m |
For sources of this data, please see the company profile
View Company Profiles
Novartis Gene Therapies
HQ
Bannockburn, US
Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
View company